Cite
HARVARD Citation
Lawitz, E. et al. (n.d.). High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award. American journal of gastroenterology. p. . [Online].